Factor XII

Definition

Factor XII, also known as Hageman factor, is a plasma serine protease that plays a crucial role in the intrinsic pathway of the blood coagulation cascade. It is an essential component in the initiation and regulation of hemostasis, the process by which the body stops bleeding.

5 Must Know Facts For Your Next Test

1. Factor XII is synthesized in the liver and circulates in the blood as an inactive zymogen (precursor enzyme).
2. Activation of factor XII occurs when it comes into contact with negatively charged surfaces, such as damaged or foreign surfaces, or with certain substances like collagen or glass.
3. Activated factor XII (factor XIIa) then initiates the intrinsic pathway of the coagulation cascade by activating factor XI, leading to the formation of a fibrin clot.
4. Factor XII deficiency is a rare genetic disorder that can lead to prolonged bleeding times, but it is generally asymptomatic and does not cause significant bleeding problems.
5. Factor XII is also involved in the activation of the kallikrein-kinin system, which can lead to the production of bradykinin and the initiation of the inflammatory response.

Review Questions

• Explain the role of factor XII in the intrinsic pathway of the coagulation cascade.
  • Factor XII, also known as Hageman factor, is a crucial component of the intrinsic pathway of the coagulation cascade. When activated, factor XII initiates a series of enzymatic reactions that ultimately lead to the formation of a fibrin clot. Specifically, activated factor XII (factor XIIa) activates factor XI, which then activates factor IX. This activation cascade continues, eventually resulting in the conversion of prothrombin to thrombin and the creation of a stable fibrin clot to stop bleeding.
• Describe the conditions that lead to the activation of factor XII and how this activation contributes to hemostasis.
  • Factor XII is activated when it comes into contact with negatively charged surfaces, such as those found in damaged or foreign materials. This can occur at the site of an injury, where the exposure of collagen or other substances can trigger the activation of factor XII. Once activated, factor XIIa initiates the intrinsic pathway of the coagulation cascade, leading to the production of thrombin and the formation of a fibrin clot. This process is crucial for hemostasis, as the fibrin clot helps to seal the damaged blood vessel and stop the bleeding.
• Analyze the potential impact of factor XII deficiency on the body's ability to maintain hemostasis and discuss any associated clinical implications.
  • Factor XII deficiency is a rare genetic disorder that can lead to prolonged bleeding times. However, it is generally asymptomatic and does not cause significant bleeding problems. This is because the intrinsic pathway, which is initiated by factor XII, is not the primary pathway for hemostasis. The extrinsic pathway, which is initiated by the exposure of tissue factor, is the dominant pathway for initiating the coagulation cascade and stopping bleeding. In the absence of factor XII, the extrinsic pathway can still function effectively to maintain hemostasis. While factor XII deficiency may result in slightly longer bleeding times, it does not typically lead to life-threatening bleeding episodes. The clinical implications of this disorder are generally mild, and individuals with factor XII deficiency may not even be aware of their condition unless it is identified through laboratory testing.

Related terms

Intrinsic Pathway:

The intrinsic pathway, also called the contact activation pathway, is one of the two main pathways of the blood coagulation cascade. It is initiated by the activation of factor XII upon contact with damaged or foreign surfaces.

Hemostasis:

Hemostasis is the process by which the body stops bleeding, either at the site of an injury or through a break in a vessel. It involves a complex series of events, including platelet activation, the coagulation cascade, and the formation of a stable fibrin clot.

Coagulation Cascade:

The coagulation cascade is a series of enzymatic reactions that lead to the formation of a fibrin clot, which helps to stop bleeding. It consists of the intrinsic and extrinsic pathways, both of which converge on the common pathway.